PENK Methylation Test for Detecting Bladder Cancer

NCT05220189 · clinicaltrials.gov ↗

UNKNOWN

Status

1549

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Hematuria; Benign

Interventions

DIAGNOSTIC_TEST: EarlyTect® Bladder Cancer test

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]